About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: April 6, 2006
Generics and Pricing
I almost missed this from the FDA. It is common knowledge that generic drugs usually mean a lower price for a chemical therapy. That is why the Hatch-Waxman Act exists. However, a study released by the FDA on April 4, … Continue reading
Posted in Pricing and Value
Comments Off on Generics and Pricing